Novartis AG
Overview
Novartis AG is a leading global healthcare company focused on developing innovative medicines to improve patient outcomes. Known for its pioneering pharmaceutical research, the company offers a wide range of products across several therapeutic areas.
Therapeutic areas
API / Drug Master Files
Novartis AG holds 3 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- NAFTIFINE HYDROCHLORIDEActive2003-08-19
- PENTETREOTIDEActive1992-10-09
- POLY (DL-LACTIDE-CO-GLYCOLIDE)Active1987-03-26
- FACILITY AND OPERATING PROCEDURES IN DORVAL, QUEBEC, CANADAInactive1993-10-14
- MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GRIMSBY, UKInactive1988-11-01
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Novartis AG in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.